Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Henry

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Physics in Medicine and Biology|January 16, 2015
Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapyLouise J Murray, Christopher M Thompson, John Lilley, et al.
BJR Open|August 12, 2021
A feasibility study of hyoscine butylbromide (buscopan) to improve image quality of cone beam computed tomography during abdominal/pelvic Stereotactic Ablative RadiotherapyFinbar Slevin, Matthew Beasley, Jim Zhong, et al.
Journal of Contemporary Brachytherapy|January 13, 2021
Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancerFinbar Slevin, Brinda Sethugavalar, Bashar Al-Qaisieh, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experienceAnn M Henry, Bashar Al-Qaisieh, Kathy Gould, et al.
Frontiers in Oncology|September 27, 2021
Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic ReviewJim Zhong, Finbar Slevin, Andrew F Scarsbrook, et al.
Journal of Applied Clinical Medical Physics|April 26, 2024
Dosimetric impact of contour editing on CT and MRI deep-learning autosegmentation for brain OARsNouf M Alzahrani, Ann M Henry, Anna K Clark, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2010
Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 yearsNicholas P Munro, Bashar Al-Qaisieh, Peter Bownes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 17, 2013
Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT)Louise J Murray, Vivian Cosgrove, John Lilley, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled TrialsPatricia Holch, Ann M Henry, Susan Davidson, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 2014
Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesionsLouise J Murray, John Lilley, Christopher M Thompson, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Physics in Medicine and Biology|January 16, 2015
Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapyLouise J Murray, Christopher M Thompson, John Lilley, et al.
BJR Open|August 12, 2021
A feasibility study of hyoscine butylbromide (buscopan) to improve image quality of cone beam computed tomography during abdominal/pelvic Stereotactic Ablative RadiotherapyFinbar Slevin, Matthew Beasley, Jim Zhong, et al.
Journal of Contemporary Brachytherapy|January 13, 2021
Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancerFinbar Slevin, Brinda Sethugavalar, Bashar Al-Qaisieh, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experienceAnn M Henry, Bashar Al-Qaisieh, Kathy Gould, et al.
Frontiers in Oncology|September 27, 2021
Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic ReviewJim Zhong, Finbar Slevin, Andrew F Scarsbrook, et al.
Journal of Applied Clinical Medical Physics|April 26, 2024
Dosimetric impact of contour editing on CT and MRI deep-learning autosegmentation for brain OARsNouf M Alzahrani, Ann M Henry, Anna K Clark, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2010
Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 yearsNicholas P Munro, Bashar Al-Qaisieh, Peter Bownes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 17, 2013
Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT)Louise J Murray, Vivian Cosgrove, John Lilley, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled TrialsPatricia Holch, Ann M Henry, Susan Davidson, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 2014
Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesionsLouise J Murray, John Lilley, Christopher M Thompson, et al.
Pageof 6